Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 796 AL 810

Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists

Bienfait KL, Menza M, Mark MH, Dobkin RD.

J Clin Neurosci. 2010 Apr;17(4):539-40. doi: 10.1016/j.jocn.2009.09.001. Epub 2010 Feb 19.

Using point process models to compare neural spiking activity in the subthalamic nucleus of Parkinson's patients and a healthy primate

Sarma SV, Eden UT, Cheng ML, Williams ZM, Hu R, Eskandar E, Brown EN.

IEEE Trans Biomed Eng. 2010 Jun;57(6):1297-305. doi: 10.1109/TBME.2009.2039213. Epub 2010 Feb 17.

A meta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1

Natale M, Bonino D, Consoli P, Alberio T, Ravid RG, Fasano M, Bucci EM.

Bioinformatics. 2010 Apr 1;26(7):946-52. doi: 10.1093/bioinformatics/btq073. Epub 2010 Feb 19.

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

Louis ED, Ferreira JJ.

Mov Disord. 2010 Apr 15;25(5):534-41. doi: 10.1002/mds.22838.

Incidental Lewy body disease: clinical comparison to a control cohort

Adler CH, Connor DJ, Hentz JG, Sabbagh MN, Caviness JN, Shill HA, Noble B, Beach TG.

Mov Disord. 2010 Apr 15;25(5):642-6. doi: 10.1002/mds.22971.

A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy

Bukhatwa S, Zeng BY, Rose S, Jenner P.

Brain Res. 2010 Apr 22;1326:174-83. doi: 10.1016/j.brainres.2010.02.045. Epub 2010 Feb 20.

Potential future neuroprotective therapies for neurodegenerative disorders and stroke

Tarawneh R, Galvin JE.

Clin Geriatr Med. 2010 Feb;26(1):125-47. doi: 10.1016/j.cger.2009.12.003.

Effective long-term subthalamic stimulation in PARK8 positive Parkinson's disease

Breit S, Wächter T, Schmid-Bielenberg D, Weiss D, Leitner P, Nägele T, Freudenstein D, Gasser T, Krüger R.

J Neurol. 2010 Jul;257(7):1205-7. doi: 10.1007/s00415-010-5493-8. Epub 2010 Feb 23.

Does cueing training improve physical activity in patients with Parkinson's disease?

Lim I, van Wegen E, Jones D, Rochester L, Nieuwboer A, Willems AM, Baker K, Hetherington V, Kwakkel G.

Neurorehabil Neural Repair. 2010 Jun;24(5):469-77. doi: 10.1177/1545968309356294. Epub 2010 Feb 23.

Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies

Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A.

J Alzheimers Dis. 2010;20 Suppl 1:S221-38. doi: 10.3233/JAD-2010-091525.

Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms

Prediger RD.

J Alzheimers Dis. 2010;20 Suppl 1:S205-20. doi: 10.3233/JAD-2010-091459.

Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline

Cunha RA, Agostinho PM.

J Alzheimers Dis. 2010;20 Suppl 1:S95-116. doi: 10.3233/JAD-2010-1408.

Targeting mitochondrial dysfunction in neurodegenerative disease: Part I

Burchell VS, Gandhi S, Deas E, Wood NW, Abramov AY, Plun-Favreau H.

Expert Opin Ther Targets. 2010 Apr;14(4):369-85. doi: 10.1517/14728221003652489.

Increase in locomotor activity after acute administration of the nicotinic receptor agonist 3-bromocytisine in rats

Abin-Carriquiry JA, Urbanavicius J, Scorza C, Rebolledo-Fuentes M, Wonnacott S, Cassels BK, Dajas F.

Eur J Pharmacol. 2010 May 25;634(1-3):89-94. doi: 10.1016/j.ejphar.2010.02.030. Epub 2010 Feb 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias